CD274 and neoplasm: This transition relies on three critical processes: (i) cross-priming of tumor-specific T cells, (ii) PD-L1 upregulation as an adaptive resistance mechanism, and (iii) T cell receptor (TCR) clonal expansion driven by ICD-induced antigen spreading (Fig. 2).